Tarsus Net Debt To E B I T D A from 2010 to 2025

TARS Stock  USD 43.91  1.35  3.17%   
Tarsus Pharmaceuticals Net Debt To EBITDA yearly trend continues to be comparatively stable with very little volatility. Net Debt To EBITDA will likely drop to 0.75 in 2025. Net Debt To EBITDA is a leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). View All Fundamentals
 
Net Debt To EBITDA  
First Reported
2010-12-31
Previous Quarter
0.78642935
Current Value
0.75
Quarterly Volatility
3.93597308
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Tarsus Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tarsus Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 7.5 M or Depreciation And Amortization of 529.3 K, as well as many indicators such as Price To Sales Ratio of 13.51, Dividend Yield of 0.0 or PTB Ratio of 9.74. Tarsus financial statements analysis is a perfect complement when working with Tarsus Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Tarsus Pharmaceuticals Correlation against competitors.
For more information on how to buy Tarsus Stock please use our How to Invest in Tarsus Pharmaceuticals guide.

Latest Tarsus Pharmaceuticals' Net Debt To E B I T D A Growth Pattern

Below is the plot of the Net Debt To E B I T D A of Tarsus Pharmaceuticals over the last few years. It is a leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). Tarsus Pharmaceuticals' Net Debt To EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tarsus Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Net Debt To E B I T D A10 Years Trend
Pretty Stable
   Net Debt To E B I T D A   
12.66.3012.80.871.470.790.75-50%104%-93%69%-46%-5%100%
       Timeline  

Tarsus Net Debt To E B I T D A Regression Statistics

Arithmetic Mean3.22
Geometric Mean2.07
Coefficient Of Variation122.42
Mean Deviation2.78
Median1.75
Standard Deviation3.94
Sample Variance15.49
Range12.1196
R-Value0.17
Mean Square Error16.12
R-Squared0.03
Significance0.53
Slope0.14
Total Sum of Squares232.38

Tarsus Net Debt To E B I T D A History

2025 0.75
2024 0.79
2023 1.47
2022 0.87
2021 12.87
2020 6.3
2019 12.69

About Tarsus Pharmaceuticals Financial Statements

Tarsus Pharmaceuticals shareholders use historical fundamental indicators, such as Net Debt To E B I T D A, to determine how well the company is positioned to perform in the future. Although Tarsus Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Tarsus Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Tarsus Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Debt To EBITDA 0.79  0.75 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Tarsus Stock Analysis

When running Tarsus Pharmaceuticals' price analysis, check to measure Tarsus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tarsus Pharmaceuticals is operating at the current time. Most of Tarsus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tarsus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tarsus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tarsus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.